Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study.
Niedersuess-Beke D, Mayrhofer K, Krauter J, Schnabel S, Gampenrieder SP, Miechowiecki J, Kiesl D, Luger F, Pfuner J, Wiesinger C, Vallet S, Andalibi H, Vais D, Banner A, Stoiber F, Spielgelberg J, Barth D, Bauernhofer T, Aufderklamm S, Weibrecht S, Mühlmann J, Mayer M, Hilbe W, Boulmé F, Klinglmair G, Heintel D, Shariat SF, Pichler M, Pichler R. Niedersuess-Beke D, et al. Among authors: pichler m. Clin Genitourin Cancer. 2024 Nov 22:102278. doi: 10.1016/j.clgc.2024.102278. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39672785 Free article.
Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer.
Parrella P, Barbano R, Jonas K, Fontana A, Barile S, Rendina M, Lo Mele A, Prencipe G, Ciuffreda L, Morritti MG, Valori VM, Graziano P, Maiello E, Copetti M, Pichler M, Pasculli B. Parrella P, et al. Among authors: pichler m. Biomedicines. 2024 Nov 17;12(11):2625. doi: 10.3390/biomedicines12112625. Biomedicines. 2024. PMID: 39595190 Free PMC article.
Primary tumor ablation in metastatic renal cell carcinoma.
Scheipner L, Incesu RB, Morra S, Baudo A, Jannello LMI, Siech C, de Angelis M, Assad A, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Tilki D, Longo N, Carmignani L, De Cobelli O, Pichler M, Ahyai S, Karakiewicz PI. Scheipner L, et al. Among authors: pichler m. Urol Oncol. 2024 Nov 12:S1078-1439(24)00699-9. doi: 10.1016/j.urolonc.2024.10.019. Online ahead of print. Urol Oncol. 2024. PMID: 39537442 Free article.
A human ex vivo skin model breaking boundaries.
Wurbs A, Karner C, Vejzovic D, Singer G, Pichler M, Liegl-Atzwanger B, Rinner B. Wurbs A, et al. Among authors: pichler m. Sci Rep. 2024 Oct 14;14(1):24054. doi: 10.1038/s41598-024-75291-7. Sci Rep. 2024. PMID: 39402181 Free PMC article.
Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study).
Ciccarese C, Büttner T, Cerbone L, Zampiva I, Monteiro FSM, Basso U, Pichler M, Vitale MG, Fiala O, Roviello G, Kopp RM, Carrozza F, Pichler R, Grillone F, Calabuig EP, Zeppellini A, Küronya Z, Galli L, Facchini G, Sunela K, Mosca A, Molina-Cerrillo J, Spinelli GP, Ansari J, Scala A, Mollica V, Grande E, Buti S, Kanesvaran R, Zakopoulou R, Bamias A, Rizzo M, Massari F, Iacovelli R, Santoni M. Ciccarese C, et al. Among authors: pichler m. Int J Cancer. 2024 Dec 1;155(11):2036-2046. doi: 10.1002/ijc.35141. Epub 2024 Sep 7. Int J Cancer. 2024. PMID: 39243397
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies.
Noeraparast M, Krajina K, Pichler R, Niedersüß-Beke D, Shariat SF, Grünwald V, Ahyai S, Pichler M. Noeraparast M, et al. Among authors: pichler m. Cancer Commun (Lond). 2024 Oct;44(10):1189-1208. doi: 10.1002/cac2.12602. Epub 2024 Aug 19. Cancer Commun (Lond). 2024. PMID: 39161208 Free PMC article. Review.
RiboScreenTM Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of Elastin.
Wimmer B, Schernthaner J, Edobor G, Friedrich A, Poeltner K, Temaj G, Wimmer M, Kronsteiner E, Pichler M, Gercke H, Huber R, Kaefer N, Rinnerthaler M, Karl T, Krauß J, Mohr T, Gerner C, Hintner H, Breitenbach M, Bauer JW, Rakers C, Kuhn D, von Hagen J, Müller N, Rathner A, Breitenbach-Koller H. Wimmer B, et al. Among authors: pichler m. Int J Mol Sci. 2024 Aug 1;25(15):8430. doi: 10.3390/ijms25158430. Int J Mol Sci. 2024. PMID: 39125999 Free PMC article.
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. JHEP Rep. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 39006503 Free PMC article.
611 results